Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease

Experimental Aging Research

Volumn 31, Issue 3, 2005, Pages 345-354

  Asita De Silva, H ^a   Gunatilake, Saman B ^a   Johnston, Carole ^b   Warden, Donald ^b   Smith, A David ^b  

^a UNIVERSITY OF KELANIYA   (Sri Lanka)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; BRAIN ATROPHY; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; FEMALE; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MALE; PREVALENCE; RISK FACTOR; SRI LANKA; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATROPHY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC MARKERS; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SRI LANKA; STATISTICS, NONPARAMETRIC; TEMPORAL LOBE;

EID: 21044438777     PISSN: 0361073X     EISSN: None     Source Type: Journal    
DOI: 10.1080/03610730590948221     Document Type: Article

References (33)

1. American Psychiatric Association. (1994). DSM-IV: Diagnostic and statistical manual of mental disorders (4th Ed.). Washington, DC: American Psychiatric Association.
2. Ball, M. J. (1977). Neuronal loss, neurofibrillary tangles granulovacuolar degeneration in the hippocampus with aging and dementia. A quantitative study. Acta Neuropatholica (Berl), 37, 111-118.
3. Budge, M., Johnston, C., Hogervorst, E., de Jager, C., Milwain, E., Iversen, S. D., Barnetson, L., King, E., & Smith, A. D. (2000). Plasma total homocysteine and cognitive performance in a volunteer elderly population. Annals of the New York Academy of Science, 903, 407-410.
4. Chandra, V., Ganguli, M., Pandav, R., Johnston, J., Belle, S., & DeKosky, S. T. (1998). Prevalence of Alzheimer's disease and other dementias in rural India: The Indo-US study. Neurology, 51, 1000-1008.
5. Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998). Folate, vitamin B12, and serum homocysteine levels in confirmed Alzheimer's disease. Archives of Neurology, 55, 1449-1455.
6. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993). Gene-dose of apolipoprotein E type allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
7. de Leon, M. J., Convit, A., George, A. E., Golomb, J., de Santi, S., Tarshish, C., Rusinek, H., Bobinski, M., Ince, C., Miller, D., & Wisniewski, H. (1996). In vivo structural studies of the hippocampus in normal aging and insipient Alzheimer's disease. Annals of the New York Academy of Science, 777, 1-13.
8. de Leon, M. J., George, A. E., Stylopoulos, L. A., Smith, G., & Miller, D. C. (1989). Early marker for Alzheimer's disease: The atrophie hippocampus. The Lancet, ii, 672-673.
9. De Silva, H. A. & Gunatilake, S. B. (2002). Mini Mental State Examination in Sinhalese: A sensitive test to screen for dementia in Sri Lanka. International Journal of Geriatric Psychiatry, 17, 134-139.
10. De Silva, H. A., Gunatilake, S. B., & Smith, A. D. (2003). Prevalence of dementia in a semi-urban community in Sri Lanka: report from a regional survey. International Journal of Geriatric Psychiatry, 18, 1-5.
11. Evans, D. A., Beckett, L. A., Field, T. S., Feng, L., Albert, M. S., Bennet, D. A., Tsycko, B., & Mayneux, R. (1997). Apolipoprotein E4 and incidence of Alzheimer's disease in a community population of older persons. Journal of the American Medical Association, 277, 822-824.
12. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., Myers, R. H., Pericak-Vance, M. A., Risch, N., & van Dujin, C. M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: A meta-analysis. Journal of the American Medical Association, 278, 1349-1356.
13. Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandev, R., Bell, S. H., & DeKosky, S. T. (2000). Apolipoprotein E polymorphism and Alzheimer's disease. Archives of Neurology, 57, 824-830.
14. Hendrie, H. C. (1974). Epidemiology of dementia and Alzheimer's disease. American Journal of Geriatric Psychiatry, 6(suppl), S3-S18.
15. Hofman, A., Ott, A., Breteler, M., Bots, M., Slooter, A. J., van Harskamp, F., van Dujin, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. The Lancet, 349, 151-154.
16. Jack, C. R., Petersen, R. C., Xu, Y. C., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999). Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology, 52, 1397-1403.
17. Jobst, K. A., Smith, A. D., Szatmari, M., Molyneux, A., Esiri, M. E., King, E., Smith, A., Jaskowski, A., McDonald, B., & Wald, N. (1992). Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. The Lancet, 340, 1179-1183.
18. Katzman, R., Zhang, M. Y., Chen, P. J., Gu, N., Jiang, S., Saitoh, T., Chen, X., Klauber, M., Thomas, R. G., Liu, W. T., & Yu, E. S. (1997). Effects of apolipoprotein on dementia and aging in the Shanghai survey of dementia. Neurology, 49, 779-785.
19. Koehler, K. M., Romero, L. J., Stauber, P. M., Pareo-Tubbeh, S. L., Liang, H. C., Baumgartner, R. N., Carry, P. J., Allen, R. H., & Stabler, S. P. (1996). Vitamin supplementation and other variables affecting serum homocysteine and methyl-malonic acid concentrations in the elderly men and women. Journal of the American College of Nutrition, 15, 364-376.
20. Kowalska, A., Asada, T., Arima, K., Kumakiri, C., Kozubski, W., Takahashi, K., & Tabira, T. (2001). Genetic analysis in patients with familial and sporadic frontotemporal dementia: Two tau mutations in only familial cases and no association with apolipoprotein E4. Dementia and Geriatric Cognitive Disorders, 12, 387-392.
21. Luthra, K., Bhargav, B., Chabbra, S., Das, N., Misra, A., Agrawal, D. P., Pandey, R. M., & Srivastava, L. M. (2002). Apolipoprotien E polymorphism in Northern Indian patients with coronary heart disease: Phenotype distribution and relationship to serum lipids and lipoproteins. Molecular Cell Biochemistry, 232, 97-102.
22. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group. Neurology, 34, 939-944.
23. Nexo, E., Eugbaek, F., Ueland, P. M., Westby, C., O'Gorman, P., Johnston, C., Kase, B. F., Guttormsen, A. B., Alfheim, I., McPartlin, J., Smith, D., Moller, J., Rasmussen, K., Clarke, R., Scott, J. M., & Refsum, H. (2000). Evaluation of novel assays in clinical chemistry: Qualification of plasma total homocysteine. Clinical Chemistry, 46, 1150-1156.
24. Press, G. A., Amaral, D. G., & Squire, L. R. (1998). Hippocampal abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging. Nature, 341, 54-57.
25. Riggs, K. M., Spiro, A., Tucker, K., & Rush, D. (1996). Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition, 63, 306-314.
26. Roses, A. D. (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annual Review of Medicine, 47, 387-400.
27. Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986). CAMDEX: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149, 698-709.
28. Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993). Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472.
29. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W., & Wolf, P. A. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 346, 476-483.
30. Smith, A. D. (2002). Homocysteine, B vitamin, and cognitive deficit in the elderly. American Journal of Clinical Nutrition, 75, 785-786.
31. Thelma, B. K., Juyal, R. C., Dodge, H. H., Pandav, R., Chandra, V., & Ganguli, M. (2001). APOE polymorphism in a rural older population-based sample in India. Human Biology, 73, 135-144.
32. Wenham, P. R., Price, W. H., & Blandell, G. (1991). Apolipoprotein E genotyping by one-stage PCR. The Lancet, 337, 1158-1159.
33. Williams, J. H., Pereira, E. A., Budge, M. M., & Bradley, K. M. (2002). Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age and Ageing, 31, 440-444.